The phase Ib TROPION-Lung02 trial is a dose-escalation and -expansion study evaluating Dato-DXd (4 or 6 mg/kg) combined with pembrolizumab (doublet) with or without platinum agents (triplet therapy) in both previously untreated and pre-treated patients with metastatic NSCLC without actionable genomic alterations
Frontiers in Cell and Developmental Biology, 13 , 1633166 Shang, Y., Song, N., He, R., & Wu, M
Providers should also address realistic expectations: creatine supports muscle performance and may help maintain lean mass, but it does not directly enhance fat loss or improve glycemic control
This treatment is gaining popularity for its skin-whitening effects and notable antioxidant properties
Therefore, to maintain healthy levels of vitamin B12 in your body and youre older, youll likely need additional injections more often